Sunitinib or pazopanib: Is there any difference between tyrosine kinase inhibitors in the pre-nivolumab setting in metastatic renal cell carcinoma? için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Sunitinib or pazopanib: Is there any difference between tyrosine kinase inhibitors in the pre-nivolumab setting in metastatic renal cell carcinoma? | 0 |
Aylık toplam ziyaret
| views | |
|---|---|
| Ocak 2025 | 0 |
| Şubat 2025 | 0 |
| Mart 2025 | 0 |
| Nisan 2025 | 0 |
| Mayıs 2025 | 0 |
| Haziran 2025 | 0 |
| Temmuz 2025 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| cureus-0012-00000010525.pdf | 14 |
